Cassava Sciences, Inc. (SAVA) earnings
Quarterly and annual SAVA reports and results, each read against the price at its own news timestamp. Back to the SAVA overview →
12 measured SAVA earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q FILANA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q FILANA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K FILANA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q CASSAVA SCIENCES INC For: Sep 30 | SEC filing · Form 10-Q | -1.60% | — | |
| Form 10-Q CASSAVA SCIENCES INC For: Jun 30 | SEC filing · Form 10-Q | +5.23% | +9.54% | |
| Form 10-Q CASSAVA SCIENCES INC For: Mar 31 | SEC filing · Form 10-Q | +2.66% | +4.73% | |
| Form 10-K CASSAVA SCIENCES INC For: Dec 31 | SEC filing · Form 10-K | -1.26% | +9.39% | |
| Form 10-Q CASSAVA SCIENCES INC For: Sep 30 | SEC filing · Form 10-Q | +1.52% | +7.80% | |
| Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024 | Press release | -0.76% | +0.02% | |
| Form 10-Q CASSAVA SCIENCES INC For: Jun 30 | SEC filing · Form 10-Q | +4.57% | -13.67% | |
| Form 10-Q CASSAVA SCIENCES INC For: Mar 31 | SEC filing · Form 10-Q | -1.18% | +0.58% | |
| Form 10-K CASSAVA SCIENCES INC For: Dec 31 | SEC filing · Form 10-K | +0.09% | -1.20% |
Keep exploring
More SAVA: analyst actions → · SEC filings → · SAVA overview →